Why attend

 

World Stem Cells & Regenerative Medicine Congress

  • Discover how best to gain market access for cell therapies
     
  • Understand how industry leaders view the clinical and commercial futures of stem cells and regenerative medicine and the effect it will have on your business
     
  • Access investment advice and partnership opportunities through the Investor Forum
     
  • Identify best practices in technology and latest updates from biotechs, through interactive roundtables
     
  • Hear pioneering innovations in tissue engineering, organ regeneration and 3D bioprinting

Download the brochure

 

Should you sponsor?

Why get involved?

Can you help advance cell therapy and regenerative medicine programs?

If so, we have an audience of stem cell entrepreneurs, innovators and disruptors looking to move their business forward.

Why sponsor?

  • Speak to a room full of stem cell experts
  • Host a roundtable and meet your customers
  • Let us organise 1-2-1 meetings for you
  • Let us generate sales leads pre-event
  • Take a private meeting room

Why exhibit?

  • Show off your latest products & innovations
  • Promote new services
  • Educate your target market
  • Generate new sales leads
  • Raise brand profile

Join us

 

60+ Expert Speakers Include

 

  • Greg Bonfiglio at World Stem Cells & Regenerative Medicine Congress 2015
    Greg Bonfiglio
    Managing Director
    Proteus Venture Partners
  • Mr Eduardo Bravo at World Stem Cells & Regenerative Medicine Congress 2015
    Mr Eduardo Bravo
    Chief Executive Officer
    TiGenix
  • Brian Dickie at World Stem Cells & Regenerative Medicine Congress 2015
    Brian Dickie
    Director of Research Development
    Motor Neurone Disease Association
  • Mr Christian Homsy at World Stem Cells & Regenerative Medicine Congress 2015
    Mr Christian Homsy
    Chief Executive Officer
    Cardio3 Biosciences
  • Mr Perry Karsen at World Stem Cells & Regenerative Medicine Congress 2015
    Mr Perry Karsen
    Executive Vice President and Chief Operations Officer
    Celgene
  • Paul Laikind at World Stem Cells & Regenerative Medicine Congress 2015
    Paul Laikind
    President and Chief Executive Officer
    ViaCyte
  • Prof Chris Mason at World Stem Cells & Regenerative Medicine Congress 2015
    Prof Chris Mason
    Director, Regenerative Medicine Bioprocessing Unit
    University College London
  • Dr Brock Reeve at World Stem Cells & Regenerative Medicine Congress 2015
    Dr Brock Reeve
    Executive Director
    The Havard Stem Cell Institute
  • Mr Keith Thompson at World Stem Cells & Regenerative Medicine Congress 2015
    Mr Keith Thompson
    Chief Executive Officer
    Cell Therapy Catapult
  • Prof Peter Weissberg at World Stem Cells & Regenerative Medicine Congress 2015
    Prof Peter Weissberg
    Medical Director
    British Heart Foundation
  • Dr Mike Leek at World Stem Cells & Regenerative Medicine Congress 2015
    Dr Mike Leek
    Chief Executive Officer
    TC Biopharm
  • Mr Geoff MacKay at World Stem Cells & Regenerative Medicine Congress 2015
    Mr Geoff MacKay
    President and Chief Executive Officer
    Organogenesis
  • Prof Alan Silman at World Stem Cells & Regenerative Medicine Congress 2015
    Prof Alan Silman
    Medical Director, Director of Policy and Health Promotion
    Arthritis Research UK
  • Mr Mark Szczypka at World Stem Cells & Regenerative Medicine Congress 2015
    Mr Mark Szczypka
    Senior Director of Applications and New Product Development
    Pall Corporation

 

Meet over 50 innovative companies in the exhibition

  • Gold Sponsor

    Cell Therapy Catapult at World Stem Cells & Regenerative Medicine Congress 2015
  • Gold Sponsor

    Octane Biotech at World Stem Cells & Regenerative Medicine Congress 2015
  • Gold Sponsor

    GE Healthcare Life Sciences at World Stem Cells & Regenerative Medicine Congress 2015
  • Gold Sponsor

    Pall Life Sciences at World Stem Cells & Regenerative Medicine Congress 2015
  • Gold Sponsor

    Lonza Inc at World Stem Cells & Regenerative Medicine Congress 2015
  • Gold Sponsor

    Progenitor Cell Therapy at World Stem Cells & Regenerative Medicine Congress 2015
  • Gold Sponsor

    Terumo BCT at World Stem Cells & Regenerative Medicine Congress 2015
  • Silver Sponsor

    Millipore at World Stem Cells & Regenerative Medicine Congress 2015
  • Silver Sponsor

    Invetech Pty Ltd at World Stem Cells & Regenerative Medicine Congress 2015
  • Associate Sponsor

    CCRM at World Stem Cells & Regenerative Medicine Congress 2015
  • Associate Sponsor

    Smith and Nephew at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    Chemometec Allerod Denmark at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    TrakCel at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    UPM at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    MedCity at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    MaSTherCell at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    WuXi AppTec Inc at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    NHS Blood and Transplant at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    Miltenyi Biotec GmbH at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    COMECER GROUP at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    Sartorius Stedim Biotech GmbH at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    Scinus at World Stem Cells & Regenerative Medicine Congress 2015
  • Exhibitor

    Cryoport Inc at World Stem Cells & Regenerative Medicine Congress 2015

Join them

 

Interactive Sessions Offer High Level Networking

 

'Very well organised conference with excellent networking facilities'

Nico Verlinden, Perkin Elmer

‘Good exhibition area, good traffic’

Rudolf Schmitt,  GE Healthcare Europe

‘Interesting talks and high level discussions with good networking’

Markus Sack, RWTH Aachen University

 

Co-located with

Be part of the conversation #WSCRM

 

New Benefit- Risk, PSUR, Benefit-Risk Assessment, drug safety

New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment

At the 2014 World Drug Safety Congress Americas, Anne Wolka, Eli Lilly and Company, gave a presentation on “New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment”. Download and learn: The rebirth of the PSUR Objective of the PBRER Critical Analysis of Benefits Critical Analysis of Risks Integrated Benefit-Risk Analysis Impact of the PBRER So What Is a […]

The post New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment appeared first on Total Biopharma.

top-50-pharmaceutical-companies-20130

Top 50 Pharmaceutical Companies 2014

The Pharmaceutical and Biotechnology continue to dominate the world’s R&D expenditure, with more companies in the top 10 than any other sector. This year, whilst Novartis has knocked Roche from their top spot, individual R&D spends by pharma and biotechs fail to compete with the likes of Volkswagen and Samsung who’s spends were around $11 […]

The post Top 50 Pharmaceutical Companies 2014 appeared first on Total Biopharma.

Asian biotechs to look beyond Asia for growth

Earlier this year at BioPharma Asia Convention, when we spoke to some speakers about their thoughts on the key growth strategy that Asian biotech companies should adopt, there seemed to be a unanimous agreement that looking beyond Asia is the way to go. “Biotech companies in Asia have to think globally, and link globally. “ […]

The post Asian biotechs to look beyond Asia for growth appeared first on Total Biopharma.

Join the Community

Innovation and strategy for pharmaceutical, biotech and R&D

Sign Up to Our Newsletter